aluates Reports

$ 0.0

Automative

Global Tumor Genomics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-12R5892

Global Tumor Genomics Market Insights Forecast to 2028

BUY CHAPTERS

Global Tumor Genomics Market Research Report 2025

Code: QYRE-Auto-12R5892

Report

June 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott Laboratories

Agilent Technologies Inc

Bio-Rad Laboratories Inc

Danaher Corporation

F Hoffmann La Roche Ltd

Fluidigm Corporation

General Electric Company

Illumina Inc

Merck KGaA

Myriad Genetics Inc

Pacific Biosciences of California, Inc.

PerkinElmer Inc

Qiagen NV

Siemens Healthineers AG

Thermo Fisher Scientific Inc

Tumor Genomics Market

The global market for Tumor Genomics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Tumor genomics, also known as cancer genomics, is an emerging sub-discipline in genomics, mainly through the high-throughput sequencing technology to associate genes with cancer. Tumor is a disease caused by the accumulation of DNA mutations that leads to an uncontrolled proliferation of cells and the formation of new organisms. The main goal of tumor genomics is to provide new methods for tumor diagnosis, tumor clinical outcome prediction and tumor target treatment by identifying new oncogenes or tumor suppressor genes.

North American market for Tumor Genomics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tumor Genomics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Tumor Genomics in Diagnostics and Monitoring is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Tumor Genomics include Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc., Merck KGaA, Myriad Genetics, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Genomics.

The Tumor Genomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor Genomics Market Report

Report Metric	Details
Report Name	Tumor Genomics Market
Segment by Type	Assays and Kits Instrument
Segment by Application	Diagnostics and Monitoring Drug Discovery and Development Biomarker Discovery
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc., Merck KGaA, Myriad Genetics, Inc., Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN, Siemens Healthineers AG, Thermo Fisher Scientific Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Genomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Genomics Market report?

Ans: The main players in the Tumor Genomics Market are Abbott Laboratories, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Fluidigm Corporation, General Electric Company, Illumina, Inc., Merck KGaA, Myriad Genetics, Inc., Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN, Siemens Healthineers AG, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Tumor Genomics Market report?

Ans: The Applications covered in the Tumor Genomics Market report are Diagnostics and Monitoring, Drug Discovery and Development, Biomarker Discovery

What are the Type segmentation covered in the Tumor Genomics Market report?

Ans: The Types covered in the Tumor Genomics Market report are Assays and Kits, Instrument

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Genomics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Assays and Kits

1.2.3 Instrument

1.3 Market by Application

1.3.1 Global Tumor Genomics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostics and Monitoring

1.3.3 Drug Discovery and Development

1.3.4 Biomarker Discovery

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor Genomics Market Perspective (2020-2031)

2.2 Global Tumor Genomics Growth Trends by Region

2.2.1 Global Tumor Genomics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tumor Genomics Historic Market Size by Region (2020-2025)

2.2.3 Tumor Genomics Forecasted Market Size by Region (2026-2031)

2.3 Tumor Genomics Market Dynamics

2.3.1 Tumor Genomics Industry Trends

2.3.2 Tumor Genomics Market Drivers

2.3.3 Tumor Genomics Market Challenges

2.3.4 Tumor Genomics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor Genomics Players by Revenue

3.1.1 Global Top Tumor Genomics Players by Revenue (2020-2025)

3.1.2 Global Tumor Genomics Revenue Market Share by Players (2020-2025)

3.2 Global Tumor Genomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tumor Genomics Revenue

3.4 Global Tumor Genomics Market Concentration Ratio

3.4.1 Global Tumor Genomics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Genomics Revenue in 2024

3.5 Global Key Players of Tumor Genomics Head office and Area Served

3.6 Global Key Players of Tumor Genomics, Product and Application

3.7 Global Key Players of Tumor Genomics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Genomics Breakdown Data by Type

4.1 Global Tumor Genomics Historic Market Size by Type (2020-2025)

4.2 Global Tumor Genomics Forecasted Market Size by Type (2026-2031)

5 Tumor Genomics Breakdown Data by Application

5.1 Global Tumor Genomics Historic Market Size by Application (2020-2025)

5.2 Global Tumor Genomics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tumor Genomics Market Size (2020-2031)

6.2 North America Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tumor Genomics Market Size by Country (2020-2025)

6.4 North America Tumor Genomics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor Genomics Market Size (2020-2031)

7.2 Europe Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tumor Genomics Market Size by Country (2020-2025)

7.4 Europe Tumor Genomics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor Genomics Market Size (2020-2031)

8.2 Asia-Pacific Tumor Genomics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tumor Genomics Market Size by Region (2020-2025)

8.4 Asia-Pacific Tumor Genomics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor Genomics Market Size (2020-2031)

9.2 Latin America Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tumor Genomics Market Size by Country (2020-2025)

9.4 Latin America Tumor Genomics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor Genomics Market Size (2020-2031)

10.2 Middle East & Africa Tumor Genomics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tumor Genomics Market Size by Country (2020-2025)

10.4 Middle East & Africa Tumor Genomics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Details

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Tumor Genomics Introduction

11.1.4 Abbott Laboratories Revenue in Tumor Genomics Business (2020-2025)

11.1.5 Abbott Laboratories Recent Development

11.2 Agilent Technologies, Inc

11.2.1 Agilent Technologies, Inc Company Details

11.2.2 Agilent Technologies, Inc Business Overview

11.2.3 Agilent Technologies, Inc Tumor Genomics Introduction

11.2.4 Agilent Technologies, Inc Revenue in Tumor Genomics Business (2020-2025)

11.2.5 Agilent Technologies, Inc Recent Development

11.3 Bio-Rad Laboratories, Inc.

11.3.1 Bio-Rad Laboratories, Inc. Company Details

11.3.2 Bio-Rad Laboratories, Inc. Business Overview

11.3.3 Bio-Rad Laboratories, Inc. Tumor Genomics Introduction

11.3.4 Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2020-2025)

11.3.5 Bio-Rad Laboratories, Inc. Recent Development

11.4 Danaher Corporation

11.4.1 Danaher Corporation Company Details

11.4.2 Danaher Corporation Business Overview

11.4.3 Danaher Corporation Tumor Genomics Introduction

11.4.4 Danaher Corporation Revenue in Tumor Genomics Business (2020-2025)

11.4.5 Danaher Corporation Recent Development

11.5 F. Hoffmann-La Roche Ltd

11.5.1 F. Hoffmann-La Roche Ltd Company Details

11.5.2 F. Hoffmann-La Roche Ltd Business Overview

11.5.3 F. Hoffmann-La Roche Ltd Tumor Genomics Introduction

11.5.4 F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Ltd Recent Development

11.6 Fluidigm Corporation

11.6.1 Fluidigm Corporation Company Details

11.6.2 Fluidigm Corporation Business Overview

11.6.3 Fluidigm Corporation Tumor Genomics Introduction

11.6.4 Fluidigm Corporation Revenue in Tumor Genomics Business (2020-2025)

11.6.5 Fluidigm Corporation Recent Development

11.7 General Electric Company

11.7.1 General Electric Company Company Details

11.7.2 General Electric Company Business Overview

11.7.3 General Electric Company Tumor Genomics Introduction

11.7.4 General Electric Company Revenue in Tumor Genomics Business (2020-2025)

11.7.5 General Electric Company Recent Development

11.8 Illumina, Inc.

11.8.1 Illumina, Inc. Company Details

11.8.2 Illumina, Inc. Business Overview

11.8.3 Illumina, Inc. Tumor Genomics Introduction

11.8.4 Illumina, Inc. Revenue in Tumor Genomics Business (2020-2025)

11.8.5 Illumina, Inc. Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Details

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Tumor Genomics Introduction

11.9.4 Merck KGaA Revenue in Tumor Genomics Business (2020-2025)

11.9.5 Merck KGaA Recent Development

11.10 Myriad Genetics, Inc.

11.10.1 Myriad Genetics, Inc. Company Details

11.10.2 Myriad Genetics, Inc. Business Overview

11.10.3 Myriad Genetics, Inc. Tumor Genomics Introduction

11.10.4 Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2020-2025)

11.10.5 Myriad Genetics, Inc. Recent Development

11.11 Pacific Biosciences of California, Inc.

11.11.1 Pacific Biosciences of California, Inc. Company Details

11.11.2 Pacific Biosciences of California, Inc. Business Overview

11.11.3 Pacific Biosciences of California, Inc. Tumor Genomics Introduction

11.11.4 Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2020-2025)

11.11.5 Pacific Biosciences of California, Inc. Recent Development

11.12 PerkinElmer

11.12.1 PerkinElmer Company Details

11.12.2 PerkinElmer Business Overview

11.12.3 PerkinElmer Tumor Genomics Introduction

11.12.4 PerkinElmer Revenue in Tumor Genomics Business (2020-2025)

11.12.5 PerkinElmer Recent Development

11.13 QIAGEN

11.13.1 QIAGEN Company Details

11.13.2 QIAGEN Business Overview

11.13.3 QIAGEN Tumor Genomics Introduction

11.13.4 QIAGEN Revenue in Tumor Genomics Business (2020-2025)

11.13.5 QIAGEN Recent Development

11.14 Siemens Healthineers AG

11.14.1 Siemens Healthineers AG Company Details

11.14.2 Siemens Healthineers AG Business Overview

11.14.3 Siemens Healthineers AG Tumor Genomics Introduction

11.14.4 Siemens Healthineers AG Revenue in Tumor Genomics Business (2020-2025)

11.14.5 Siemens Healthineers AG Recent Development

11.15 Thermo Fisher Scientific Inc.

11.15.1 Thermo Fisher Scientific Inc. Company Details

11.15.2 Thermo Fisher Scientific Inc. Business Overview

11.15.3 Thermo Fisher Scientific Inc. Tumor Genomics Introduction

11.15.4 Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2020-2025)

11.15.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Agilent Technologies Inc

Bio-Rad Laboratories Inc

Danaher Corporation

F Hoffmann La Roche Ltd

Fluidigm Corporation

General Electric Company

Illumina Inc

Merck KGaA

Myriad Genetics Inc

Pacific Biosciences of California, Inc.

PerkinElmer Inc

Qiagen NV

Siemens Healthineers AG

Thermo Fisher Scientific Inc

List of Tables

Table 1. Global Tumor Genomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Assays and Kits

Table 3. Key Players of Instrument

Table 4. Global Tumor Genomics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Tumor Genomics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Tumor Genomics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Tumor Genomics Market Share by Region (2020-2025)

Table 8. Global Tumor Genomics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Tumor Genomics Market Share by Region (2026-2031)

Table 10. Tumor Genomics Market Trends

Table 11. Tumor Genomics Market Drivers

Table 12. Tumor Genomics Market Challenges

Table 13. Tumor Genomics Market Restraints

Table 14. Global Tumor Genomics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Tumor Genomics Market Share by Players (2020-2025)

Table 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)

Table 17. Ranking of Global Top Tumor Genomics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Tumor Genomics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Tumor Genomics, Headquarters and Area Served

Table 20. Global Key Players of Tumor Genomics, Product and Application

Table 21. Global Key Players of Tumor Genomics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tumor Genomics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Tumor Genomics Revenue Market Share by Type (2020-2025)

Table 25. Global Tumor Genomics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Tumor Genomics Revenue Market Share by Type (2026-2031)

Table 27. Global Tumor Genomics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Tumor Genomics Revenue Market Share by Application (2020-2025)

Table 29. Global Tumor Genomics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Tumor Genomics Revenue Market Share by Application (2026-2031)

Table 31. North America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Tumor Genomics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Tumor Genomics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Tumor Genomics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Tumor Genomics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Tumor Genomics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Tumor Genomics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Laboratories Company Details

Table 47. Abbott Laboratories Business Overview

Table 48. Abbott Laboratories Tumor Genomics Product

Table 49. Abbott Laboratories Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 50. Abbott Laboratories Recent Development

Table 51. Agilent Technologies, Inc Company Details

Table 52. Agilent Technologies, Inc Business Overview

Table 53. Agilent Technologies, Inc Tumor Genomics Product

Table 54. Agilent Technologies, Inc Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 55. Agilent Technologies, Inc Recent Development

Table 56. Bio-Rad Laboratories, Inc. Company Details

Table 57. Bio-Rad Laboratories, Inc. Business Overview

Table 58. Bio-Rad Laboratories, Inc. Tumor Genomics Product

Table 59. Bio-Rad Laboratories, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 60. Bio-Rad Laboratories, Inc. Recent Development

Table 61. Danaher Corporation Company Details

Table 62. Danaher Corporation Business Overview

Table 63. Danaher Corporation Tumor Genomics Product

Table 64. Danaher Corporation Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 65. Danaher Corporation Recent Development

Table 66. F. Hoffmann-La Roche Ltd Company Details

Table 67. F. Hoffmann-La Roche Ltd Business Overview

Table 68. F. Hoffmann-La Roche Ltd Tumor Genomics Product

Table 69. F. Hoffmann-La Roche Ltd Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 70. F. Hoffmann-La Roche Ltd Recent Development

Table 71. Fluidigm Corporation Company Details

Table 72. Fluidigm Corporation Business Overview

Table 73. Fluidigm Corporation Tumor Genomics Product

Table 74. Fluidigm Corporation Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 75. Fluidigm Corporation Recent Development

Table 76. General Electric Company Company Details

Table 77. General Electric Company Business Overview

Table 78. General Electric Company Tumor Genomics Product

Table 79. General Electric Company Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 80. General Electric Company Recent Development

Table 81. Illumina, Inc. Company Details

Table 82. Illumina, Inc. Business Overview

Table 83. Illumina, Inc. Tumor Genomics Product

Table 84. Illumina, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 85. Illumina, Inc. Recent Development

Table 86. Merck KGaA Company Details

Table 87. Merck KGaA Business Overview

Table 88. Merck KGaA Tumor Genomics Product

Table 89. Merck KGaA Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 90. Merck KGaA Recent Development

Table 91. Myriad Genetics, Inc. Company Details

Table 92. Myriad Genetics, Inc. Business Overview

Table 93. Myriad Genetics, Inc. Tumor Genomics Product

Table 94. Myriad Genetics, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 95. Myriad Genetics, Inc. Recent Development

Table 96. Pacific Biosciences of California, Inc. Company Details

Table 97. Pacific Biosciences of California, Inc. Business Overview

Table 98. Pacific Biosciences of California, Inc. Tumor Genomics Product

Table 99. Pacific Biosciences of California, Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 100. Pacific Biosciences of California, Inc. Recent Development

Table 101. PerkinElmer Company Details

Table 102. PerkinElmer Business Overview

Table 103. PerkinElmer Tumor Genomics Product

Table 104. PerkinElmer Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 105. PerkinElmer Recent Development

Table 106. QIAGEN Company Details

Table 107. QIAGEN Business Overview

Table 108. QIAGEN Tumor Genomics Product

Table 109. QIAGEN Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 110. QIAGEN Recent Development

Table 111. Siemens Healthineers AG Company Details

Table 112. Siemens Healthineers AG Business Overview

Table 113. Siemens Healthineers AG Tumor Genomics Product

Table 114. Siemens Healthineers AG Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 115. Siemens Healthineers AG Recent Development

Table 116. Thermo Fisher Scientific Inc. Company Details

Table 117. Thermo Fisher Scientific Inc. Business Overview

Table 118. Thermo Fisher Scientific Inc. Tumor Genomics Product

Table 119. Thermo Fisher Scientific Inc. Revenue in Tumor Genomics Business (2020-2025) & (US$ Million)

Table 120. Thermo Fisher Scientific Inc. Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Tumor Genomics Picture

Figure 2. Global Tumor Genomics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tumor Genomics Market Share by Type: 2024 VS 2031

Figure 4. Assays and Kits Features

Figure 5. Instrument Features

Figure 6. Global Tumor Genomics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Tumor Genomics Market Share by Application: 2024 VS 2031

Figure 8. Diagnostics and Monitoring Case Studies

Figure 9. Drug Discovery and Development Case Studies

Figure 10. Biomarker Discovery Case Studies

Figure 11. Tumor Genomics Report Years Considered

Figure 12. Global Tumor Genomics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Tumor Genomics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Tumor Genomics Market Share by Region: 2024 VS 2031

Figure 15. Global Tumor Genomics Market Share by Players in 2024

Figure 16. Global Top Tumor Genomics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Genomics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Tumor Genomics Revenue in 2024

Figure 18. North America Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Tumor Genomics Market Share by Country (2020-2031)

Figure 20. United States Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Tumor Genomics Market Share by Country (2020-2031)

Figure 24. Germany Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Tumor Genomics Market Share by Region (2020-2031)

Figure 32. China Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Tumor Genomics Market Share by Country (2020-2031)

Figure 40. Mexico Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Tumor Genomics Market Share by Country (2020-2031)

Figure 44. Turkey Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Tumor Genomics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Abbott Laboratories Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 48. Agilent Technologies, Inc Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 50. Danaher Corporation Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 52. Fluidigm Corporation Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 53. General Electric Company Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 54. Illumina, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 55. Merck KGaA Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 56. Myriad Genetics, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 57. Pacific Biosciences of California, Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 58. PerkinElmer Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 59. QIAGEN Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 60. Siemens Healthineers AG Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 61. Thermo Fisher Scientific Inc. Revenue Growth Rate in Tumor Genomics Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Genomics Software Market Research Report 2024

Global Genomic Testing in Cancer Market Research Report 2024

Global Clinical Next Generation Sequencing Market Insights Forecast to 2030

Global Cancer Genomic Testing Market Research Report 2024

Global Precision Cancer Medicine Market Research Report 2024

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Global Clinical Oncology Next Generation Sequencing Market Research Report 2024

Global Tumor Marker Testing Market Research Report 2024

Global Cancer Tumor Profiling Market Insights Forecast to 2030

Global Genomic Data Analysis and Interpretation Market Research Report 2024

Global Metagenomics in Healthcare Market Research Report 2024

Global Tumor Tracking System Market Insights Forecast to 2030

Global Personalized Cancer Medicine Market Research Report 2025

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Global Next Generation Oncology Solution Market Research Report 2024

Omics Based Clinical Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Genomics Solutions Market Research Report 2024

Global Agriculture Genomics Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions